Forbes
@forbes·2.1M subscribers·11.3K videos
The Case For Regeneron's Eye Drug
Posted
June 15, 2011
Views
1,360
Likes
4
Engagement
0.29%
June 15, 2011
1,360
4
0.29%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
2:44Now PlayingSenior Editor Matthew Herper on why Eylea could be a great drug, and why investors are misreading a big government study of medicines in macular degeneration.
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
